−0.0382CHF
−49.38 MCHF
1.30 B
About KINARUS N
Sector
CEO
Alexander Bausch
Headquarters
Basel
Website
Founded
1997
ISIN
CH0009115129
FIGI
BBG000BGX6H3
Kinarus Therapeutics Holding AG is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases. The company was founded on April 8, 1997 and is headquartered in Basel, Switzerland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KNRS is 0.0038 CHF — it has increased by 5.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange KINARUS N stocks are traded under the ticker KNRS.
KNRS stock is 18.75% volatile and has beta coefficient of 0.27. Check out the list of the most volatile stocks — is KINARUS N there?
Yes, you can track KINARUS N financials in yearly and quarterly reports right on TradingView.
KNRS stock has risen by 18.75% compared to the previous week, the last month showed zero change in price, over the last year KINARUS N has showed a 65.45% decrease.
KNRS net income for the last quarter is −47.33 M CHF, while the quarter before that showed −2.05 M CHF of net income which accounts for −2.21 K% change. Track more KINARUS N financial stats to get the full picture.
Today KINARUS N has the market capitalization of 4.69 M, it has decreased by 5.26% over the last week.
No, KNRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KNRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KINARUS N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KINARUS N technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KINARUS N stock shows the sell signal. See more of KINARUS N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.